News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Onyx Pharmaceuticals, Inc. Names Schafer Acting CFO Following Resignation Of Hollings Renton
April 19, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LOS ANGELES, April 18 (Reuters) - Onyx Pharmaceuticals Inc (ONXX.O: Quote, Profile, Research) on Tuesday said it named Gregory Schafer as acting chief financial officer, effective immediately.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Earnings
Novartis CEO Brushes Off Tariffs but Says Trump Pricing Controls Would Be ‘Devastating’
April 29, 2025
·
3 min read
·
Annalee Armstrong
Pipeline
AstraZeneca Abandons Neuroscience, Prioritizes Weight Loss, Immunology
April 29, 2025
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Biohaven Grabs a Foothold With $600M Windfall From Oberland Capital
April 29, 2025
·
2 min read
·
Tristan Manalac
Earnings
Regeneron Shares Tumble as Eylea Declines Make for a ‘Messy Quarter’ To Come
April 29, 2025
·
1 min read
·
Annalee Armstrong
